SCHEMBL3732151

SCHEMBL3732151

COc1cccc(-c2ccc(N)c(OC(F)(F)F)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.50
ALDH1A1 P00352 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
PGR P06401 1/20 0.47
AR P10275 1/20 0.47
DHODH Q02127 1/20 0.47
MAOB P27338 2/20 0.46
HDAC2 Q92769 1/20 0.45
BACE1 P56817 2/20 0.45
CTSD P07339 1/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MAPT P10636 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
BRD4 O60885 1/20 0.44
MAP4K4 O95819 1/20 0.44
FYN P06241 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3733523 0.85 MAPT (0.54) CYP3A4ALDH1A1TDP1TSHRHSD17B10
SCHEMBL990337 0.84 CYP3A4 (0.71) CYP3A4ALDH1A1TDP1TSHRHSD17B10
SCHEMBL30482672 0.84 CYP3A4 (0.71) CYP3A4ALDH1A1TDP1TSHRHSD17B10
SCHEMBL25369158 0.82 ALDH1A1 (0.63) CYP3A4ALDH1A1TDP1TSHRHSD17B10
SCHEMBL6927527 0.82 ALDH1A1 (0.54) CYP3A4ALDH1A1TDP1TSHRHSD17B10
SCHEMBL28929835 0.81 HSD17B10 (0.46) CYP3A4ALDH1A1TDP1TSHRHSD17B10
SCHEMBL29655214 0.77 MAOB (0.56) CYP3A4ALDH1A1TDP1TSHRHSD17B10
SCHEMBL13581001 0.77 ALDH1A1 (0.65) CYP3A4ALDH1A1TDP1TSHRHSD17B10
SCHEMBL1337887 0.76 MAOB (0.55) CYP3A4ALDH1A1PGRARMAOB
SCHEMBL30996181 0.76 ABL1 (0.61) CYP3A4ALDH1A1PGRARMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8691852-B2 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors AMIRALL, S.A. (ES) 2014-04-08 US disclosed
US-20120294854-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. 2012-11-22 US disclosed
US-8258308-B2 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors LABORATORIOS ALMIRALL, S.A. (ES) 2012-09-04 US disclosed
EP-2121614-B1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS ALMIRALL SA (ES) 2012-06-20 EP disclosed
US-20100074898-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2010-03-25 US disclosed
EP-2121614-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS Almirall, S.A. (ES) 2009-11-25 EP disclosed
WO-2008077639-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2008-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100074898-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS DHODH, NQO2, DAO CYP3A4 2249/4885ALDH1A1 147/4885TDP1 1515/4885
US-20120294854-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS DHODH, NQO2, DAO CYP3A4 2249/4885ALDH1A1 147/4885TDP1 1515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.